Notably, representing 22Rv1, DU-145 and PC-3 cell lines different stages of tumour progression, it is not excluded that lower levels of eEF1A2 could be predictable of the outcome as found for breast tumours (Kulkarni et al, 2007). The gene discussed is EEF1A2; the disease is breast neoplasm.